Building a Better Meniscus
Posted on 2006-10-23 15:58:26 in
Human Enhancement |
Researchers at UQ's AIBN are developing an artificial meniscus to replace damaged knee cartilage.
The meniscus is the knee's shock absorber. It is a cartilage spacer found between the thigh and shin bones, preventing friction and absorbing approximately one third of the impact load that the joint cartilage surface experiences.
AIBN's Associate Professor Justin Cooper-White heads the project, which is supported by UQ's Faculty of Health Sciences and the Mater Medical Research Institute, and also capitalises on the cell biology expertise of AIBN's Professor Julie Campbell.
In the latest round of Australian Research Council Discovery Projects announced recently, Professor Campbell was awarded $430,000 to develop a meniscal implant to benefit the millions of people annually affected by meniscus damage or loss.
The project aims to develop a tissue-engineered meniscus using tailored three-dimensional scaffolds and mesenchymal stem cells (precursors of the meniscus).
"Elite athletes are not the only people who suffer meniscal damage," Dr Cooper-White said.
"The general wear and tear of normal life can cause damage requiring surgery.
"In fact, in any gathering of people, about 50 percent of the group will have a damaged meniscus and some may not have any meniscus in one or both of their knees.
"Unlike other body tissues, the meniscus does not repair itself because only a very small part receives blood, which is why surgery is often needed.
"While most patients quickly recover from a meniscusectomy, long-term issues such as early arthritis of the knee joint are common."
Dr Cooper-White said the project had two parts. The first was to produce viable structural and functional scaffolds capable of promoting the growth of mesenchymal stem cells, and differentiate these cells into meniscal tissue using a specially designed bioreactor.
Secondly, the team would investigate the way these structures, laden with mesenchymal stem cells, could be incorporated into the body.
"The holy grail would be to harvest some mesenchymal stem cells from the patient, combine them with the scaffolds and appropriate growth factors and then insert this matrix into the knee so the patient effectively regrows their meniscus," he said.
"Alternatively, we are attempting to create an artificial environment mimicking as closely as possible the meniscus and capable of recruiting cells from within the meniscal cavity to differentiate these cells into the various types that make up a healthy meniscus.
"Both of these techniques require many years of research. To be successful we need a thorough understanding of how mesenchymal stem cells interact with scaffolds and how to optimise conditions promoting the cell growth around these scaffolds.
"The scaffold, while encouraging cell growth, must also degrade at the correct rate so that all that remains is meniscal tissue.
"We don't know which approach will be the most effective clinically, and this is why we are investigating the possibility of the artificial environment as well as the insertion method."
Dr Cooper-White said the research team also needed to be able to grow, or manufacture, the artificial meniscus reliably and quickly, suiting the circumstances of each patient.
Read Full Story
The meniscus is the knee's shock absorber. It is a cartilage spacer found between the thigh and shin bones, preventing friction and absorbing approximately one third of the impact load that the joint cartilage surface experiences.
AIBN's Associate Professor Justin Cooper-White heads the project, which is supported by UQ's Faculty of Health Sciences and the Mater Medical Research Institute, and also capitalises on the cell biology expertise of AIBN's Professor Julie Campbell.
In the latest round of Australian Research Council Discovery Projects announced recently, Professor Campbell was awarded $430,000 to develop a meniscal implant to benefit the millions of people annually affected by meniscus damage or loss.
The project aims to develop a tissue-engineered meniscus using tailored three-dimensional scaffolds and mesenchymal stem cells (precursors of the meniscus).
"Elite athletes are not the only people who suffer meniscal damage," Dr Cooper-White said.
"The general wear and tear of normal life can cause damage requiring surgery.
"In fact, in any gathering of people, about 50 percent of the group will have a damaged meniscus and some may not have any meniscus in one or both of their knees.
"Unlike other body tissues, the meniscus does not repair itself because only a very small part receives blood, which is why surgery is often needed.
"While most patients quickly recover from a meniscusectomy, long-term issues such as early arthritis of the knee joint are common."
Dr Cooper-White said the project had two parts. The first was to produce viable structural and functional scaffolds capable of promoting the growth of mesenchymal stem cells, and differentiate these cells into meniscal tissue using a specially designed bioreactor.
Secondly, the team would investigate the way these structures, laden with mesenchymal stem cells, could be incorporated into the body.
"The holy grail would be to harvest some mesenchymal stem cells from the patient, combine them with the scaffolds and appropriate growth factors and then insert this matrix into the knee so the patient effectively regrows their meniscus," he said.
"Alternatively, we are attempting to create an artificial environment mimicking as closely as possible the meniscus and capable of recruiting cells from within the meniscal cavity to differentiate these cells into the various types that make up a healthy meniscus.
"Both of these techniques require many years of research. To be successful we need a thorough understanding of how mesenchymal stem cells interact with scaffolds and how to optimise conditions promoting the cell growth around these scaffolds.
"The scaffold, while encouraging cell growth, must also degrade at the correct rate so that all that remains is meniscal tissue.
"We don't know which approach will be the most effective clinically, and this is why we are investigating the possibility of the artificial environment as well as the insertion method."
Dr Cooper-White said the research team also needed to be able to grow, or manufacture, the artificial meniscus reliably and quickly, suiting the circumstances of each patient.
Read Full Story
Health Headlines MORE »
For every 10 g per day increase in soluble fiber intake, a woman may reduce her risk of breast cancer by up to 26%.
Peptides from soybeans modulate neurotransmitters, thereby helping to boost circulation in the brain.
Capsaicin (found in hot peppers) and capsiates (present in sweet peppers) exert modest weight management benefits.
While over 20% of U.S. adults receive periodic health examinations each year, many do not receive recommended preventive screening tests and counseling services
Researchers from Norway suggest a mechanism by which stress may make a person fat, and being obese may create stress.
Swedish researchers report that people who are short on sleep experience greater levels of hunger.
Among women with Generalized Anxiety Disorder (GAD), regular physical activity helps to reduce anxiety, irritability, feelings of tension, low energy and pain.
For every 100 mg per-day increase in magnesium in the diet, stroke risk may decline by up to 9%.
The best male marathon runners over age 65, and the best female marathon runners over age 45, continue to consistently improve their performance.
UCLA-led team safely uses human embryonic stem cells to treat macular degeneration.
ANTI-AGING TIP OF THE DAY
In Working Order
Men and women who stay mentally engaged in their original occupational field fare after retirement fare best mentally. University of Maryland (Maryland, USA) researchers studied 12,189 retired men and women, ages 51 to 61 years at the beginning of the study. The team revealed that those retirees who continued to work in a bridge job experienced fewer major diseases...
»
MORE